Athersys
ATHX
#11224
Rank
HK$6.53 M
Marketcap
HK$0.11
Share price
-33.50%
Change (1 day)
-98.89%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -HK$0.33 Billion

According to Athersys's latest financial reports the company's current earnings are HK$0.08 Million. In 2022 the company made an earning of -HK$0.61 Billion, an increase over its 2021 earnings that were of -HK$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -HK$0.33 Billion-45.89%
2022 -HK$0.61 Billion-11.54%
2021 -HK$0.69 Billion11.14%
2020 -HK$0.62 Billion72.2%
2019 -HK$0.36 Billion77.29%
2018 -HK$0.21 Billion-22.91%
2017 -HK$0.27 Billion111.89%
2016 -HK$0.13 Billion-8.52%
2015 -HK$0.14 Billion-40.81%
2014 -HK$0.23 Billion18.62%
2013 -HK$0.2 Billion
2011 -HK$0.11 Billion19.71%
2010 -HK$90.33 Million-26.28%
2009 -HK$0.13 Billion-18.21%
2008 -HK$0.15 Billion-8.28%
2007 -HK$0.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$205.65 B-62,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$54.20 B-16,638.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$80.72 B-24,732.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$56.18 B-17,245.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$60.34 B-18,513.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$93.46 B-28,618.75%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
HK$1.35 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$23.9 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-HK$4.92 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA